Financhill
Buy
53

RXST Quote, Financials, Valuation and Earnings

Last price:
$12.66
Seasonality move :
7.09%
Day range:
$12.60 - $13.00
52-week range:
$6.32 - $39.37
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.61x
P/B ratio:
1.88x
Volume:
587.6K
Avg. volume:
880.2K
1-year change:
-64.84%
Market cap:
$518.9M
Revenue:
$139.9M
EPS (TTM):
-$0.88

Analysts' Opinion

  • Consensus Rating
    RxSight, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 7 Hold ratings, and 0 Sell ratings.
  • Price Target Downside
    According to analysts' consensus price target of $10.00, RxSight, Inc. has an estimated downside of -21.64% from its current price of $12.62.
  • Price Target Upside
    According to analysts, the highest upside price target is $14.00 representing -100% upside increase from its current price of $12.62.

Fair Value

  • According to the consensus of 7 analysts, RxSight, Inc. has -21.64% downside to fair value with a price target of $10.00 per share.

RXST vs. S&P 500

  • Over the past 5 trading days, RxSight, Inc. has overperformed the S&P 500 by 0.55% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • RxSight, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • RxSight, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter RxSight, Inc. reported revenues of $30.3M.

Earnings Growth

  • RxSight, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter RxSight, Inc. reported earnings per share of -$0.24.
Enterprise value:
302.9M
EV / Invested capital:
--
Price / LTM sales:
3.61x
EV / EBIT:
--
EV / Revenue:
2.13x
PEG ratio (5yr expected):
-2.01x
EV / Free cash flow:
-13.65x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$106.5M
Return On Assets:
-11.43%
Net Income Margin (TTM):
-25.15%
Return On Equity:
-12.84%
Return On Invested Capital:
-12.32%
Operating Margin:
-40.14%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $76.6M $128.3M $142.1M $35.3M $30.3M
Gross Profit $43.5M $87.8M $106.5M $25.2M $24.2M
Operating Income -$54.2M -$39.1M -$45.5M -$9.2M -$12.2M
EBITDA -$50.1M -$34.9M -$42.5M -$8.1M -$11.3M
Diluted EPS -$1.72 -$0.82 -$0.88 -$0.16 -$0.24
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $186.3M $139.2M $167.9M $286.8M $283.9M
Total Assets $203.7M $155.7M $181.9M $310.5M $308.5M
Current Liabilities $9.2M $16.4M $18.9M $22.6M $22.3M
Total Liabilities $52.8M $59.7M $20.4M $33.2M $32.6M
Total Equity $150.9M $96M $161.5M $277.3M $276M
Total Debt $43.7M $43.5M $1.4M $10.6M $10.3M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$47.8M -$22.6M -$18.7M $730K -$1.2M
Cash From Investing -$16.3M -$96.1M $27.8M -$9.3M -$9M
Cash From Financing $64.9M $125.5M $3.8M $798K -$530K
Free Cash Flow -$51.4M -$28.8M -$22.2M -$373K -$1.8M
RXST
Sector
Market Cap
$518.9M
$28.7M
Price % of 52-Week High
32.06%
52.89%
Dividend Yield
0%
0%
Shareholder Yield
-1.6%
-1.4%
1-Year Price Total Return
-64.84%
-19%
Beta (5-Year)
--
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $12.54
200-day SMA
Sell
Level $12.81
Bollinger Bands (100)
Buy
Level 7.8 - 10.5
Chaikin Money Flow
Buy
Level 7.9M
20-day SMA
Buy
Level $11.27
Relative Strength Index (RSI14)
Buy
Level 68.73
ADX Line
Buy
Level 33.19
Williams %R
Sell
Level -18.2932
50-day SMA
Buy
Level $9.70
MACD (12, 26)
Buy
Level 0.93
25-day Aroon Oscillator
Buy
Level 92
On Balance Volume
Neutral
Level 2.5M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (19.102)
Buy
CA Score (Annual)
Level (0.8207)
Sell
Beneish M-Score (Annual)
Level (2.4965)
Sell
Momentum Score
Level (1)
Buy
Ohlson Score
Level (-0.5793)
Buy
Piotroski F Score (Annual)
Level (7)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Stock Forecast FAQ

In the current month, RXST has received 0 Buy ratings 7 Hold ratings, and 0 Sell ratings. The RXST average analyst price target in the past 3 months is $10.00.

  • Where Will RxSight, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that RxSight, Inc. share price will drop to $10.00 per share over the next 12 months.

  • What Do Analysts Say About RxSight, Inc.?

    Analysts are divided on their view about RxSight, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that RxSight, Inc. is a Sell and believe this share price will rise from its current level to $8.00.

  • What Is RxSight, Inc.'s Price Target?

    The price target for RxSight, Inc. over the next 1-year time period is forecast to be $10.00 according to 7 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.

  • Is RXST A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for RxSight, Inc. is a Hold. 7 of 7 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of RXST?

    You can purchase shares of RxSight, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase RxSight, Inc. shares.

  • What Is The RxSight, Inc. Share Price Today?

    RxSight, Inc. was last trading at $12.66 per share. This represents the most recent stock quote for RxSight, Inc.. Yesterday, RxSight, Inc. closed at $12.62 per share.

  • How To Buy RxSight, Inc. Stock Online?

    In order to purchase RxSight, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Are the Best AI Power Stocks?
What Are the Best AI Power Stocks?

As the construction of AI infrastructure accelerates, the gap between…

Is IONQ The Best Quantum Stock to Buy?
Is IONQ The Best Quantum Stock to Buy?

Riding a wave of investor enthusiasm for the technology, quantum…

Is JetBlue The Best Airline Stock?
Is JetBlue The Best Airline Stock?

Following a general trend of improvement among airline stocks, shares…

Stock Ideas

Sell
47
Is NVDA Stock a Buy?

Market Cap: $4.3T
P/E Ratio: 60x

Buy
58
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
73
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 39x

Alerts

Buy
80
FEIM alert for Dec 13

Frequency Electronics, Inc. [FEIM] is up 28.76% over the past day.

Buy
57
MOD alert for Dec 13

Modine Manufacturing Co. [MOD] is down 15.32% over the past day.

Sell
42
OKLO alert for Dec 13

Oklo, Inc. [OKLO] is down 14.91% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock